Local Rx import programs find fewer takers

Butler, Kelley M.
January 2007
Employee Benefit News;Jan2007, Vol. 21 Issue 1, p1
The article reports on the decrease in drug purchase by U.S. customers at Canadian Internet pharmacies in 2005. A state audit of Illinois shows that I-SaveRx, an importation outlet, had served fewer than 4,000 residents in the state and 1,265 people in other states. The Food and Drug Administration (FDA) stated that it cannot guarantee the imported drugs' safety and efficacy. Factors contributing to the decline of prescription importation are also discussed.


Related Articles

  • Ominous Prospects For The Aging. Miller, Henry I. // Business Journal (Central New York);1/13/2006, Vol. 20 Issue 2, p27 

    The article focuses on a growing reaction against the pharmaceutical industry which is affecting the development and marketing of drugs in the United States. It also states the emphasis on drug safety by the United States Food & Drug Administration (FDA). The pharmaceutical industry is facing...

  • More Funds Needed Abroad. Drakulich, Angie // Pharmaceutical Technology;Jan2008, Vol. 32 Issue 1, p23 

    The article reports on the increased funding needed by the U.S. Food and Drug Administration (FDA) for overseas drug inspection. FDA announces that a total of $16 million is needed for foreign inspection and $56 million is required with the integration of domestic drug inspection. However, it...

  • Process Validation. Levenson, Michele; Chatterjee, Bikash // Pharmaceutical Processing;Jul/Aug2013, Vol. 28 Issue 6, p42 

    The article focuses on the New Process Validation Guidance issued by the U.S. Food and Drug Administration (FDA). Implementing an effective verification and control strategy to ensure process and product performance is important in the new Process Validation Guidance. The new guidance departs...

  • Manufacturers optimistic ahead of FDA review. Houlton, Sarah // Chemical Week;2/19/2003, Vol. 165 Issue 7, p30 

    Reports on the optimism of drug manufacturers on the drug approval rate by the U.S. Food and Drug Administration (FDA) for the year 2003. Goal of the drug review of the FDA; Changes in the pharmaceutical sector; Factors the contributed to the decline of the drug approval rate.

  • Here's to Innovation. Hoffman, Michelle // Pharmaceutical Technology;Dec2007, Vol. 31 Issue 12, p14 

    The article shares the author's insights regarding innovations in the drug industry in the U.S. The author points to the need for drug makers, inspectors and consumers to demand that manufacturers produce drugs that are effective. She mentions that the demand for better drugs will offer a...

  • Outrage Over Drug Prices. Wechsler, Jill // Pharmaceutical Representative;Jul2011, Vol. 41 Issue 7, p30 

    The article focuses on issues concerning over drug prices as well as the policies implemented by the U.S. Food and Drug Administration (FDA). It notes that increasing prices for new and important therapies raise concerns regarding access and impact on public and private health plans. FDA's...

  • Labels and Liability. Wechsler, Jill // Pharmaceutical Executive;Mar2006, Vol. 26 Issue 3, p50 

    The article focuses on new regulations on drug labeling imposed by the United States Food and Drug Administration and its implications to the pharmaceutical industry. The author informs that pharmaceutical companies are wary that the new labeling format will expose them to liability suits from...

  • Preemption, tort reform, and pharmaceutical claims. Thornton, Russell G. // Baylor University Medical Center Proceedings;Jan2008, Vol. 21 Issue 1, p82 

    The article provides information on medicolegal issues in the U.S. The pharmaceutical industry is pushing an agenda to essentially eliminate the ability of individuals to pursue failure-to-warn claims against manufacturers, regardless of the adequacy of the warning provided. On the other hand,...

  • FDA moving quickly on counterfeit Rx drugs. Zwillich, Todd // Drug Topics;11/3/2003, Vol. 147 Issue 21, p27 

    Focuses on the efforts of the U.S. Food and Drug Administration to control prescription drug counterfeiting. Promotion of public education and the use of computerized tracking technologies; Concern of pharmacy groups over additional costs to comply with tracking measures; Call of the American...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics